Insmed | Capital Ordinário



Ordinary Share Capital Alterar Data
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Cytokinetics USD 119.6M 119.48M 2025-06
DBV Technologies USD 11.65M 1000 2025-03
Dynavax Technologies USD 117.23M 117.11M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Insmed USD 211.11M 209.29M 2025-06
Novartis USD 793M 0 2024-12
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Insmed Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.